Persistence with teriparatide in patients with osteoporosis: the UK experience-Reference-Cited by-同舟云学术

Persistence with teriparatide in patients with osteoporosis: the UK experience

Published:2006-07-06 Issue:11 Volume:17 Page:1626-1629
ISSN:0937-941X
Container-title:Osteoporosis International
language:en
Short-container-title:Osteoporos Int

Author:

Arden N. K.,Earl S.,Fisher D. J.,Cooper C.,Carruthers S.,Goater M.

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1007/s00198-006-0171-5.pdf

Reference12 articles.

1. Cooper C (1997) The crippling consequences of fractures and their impact on quality of life. Am J Med 103(2A):12S–17S

2. Bocuzzi SJ, Folz SH, Omar MA, Kahler KH (2005) Assessment of adherence and persistence with daily and weekly dosing regimens of oral bisphosphonates. Osteoporos Int 16(Suppl 3):Abstract OC10

3. Cramer JA, Amonkar MM, Hebborn A, Altman R (2005) Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis. Curr Med Res Opin 21(9):1453–1460

4. McCombs J, Thiebaud P, McLaughlin-Miley C, Shi J (2004) Compliance with drug therapies for the treatment and prevention of osteoporosis. Maturitas 48(3):271–287

5. Cano A (1994) Compliance to hormone replacement therapy in menopausal women controlled in a third level academic centre. Maturitas 20(2–3):91–99

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of the Continuation Rate of Twice-Weekly and Weekly Teriparatide Administration in a Rural Area;The Tohoku Journal of Experimental Medicine;2023

2. Real-world persistence of twice-weekly teriparatide and factors associated with the discontinuation in patients with osteoporosis;Journal of Bone and Mineral Metabolism;2022-06-27

3. Adherence to dosing schedule of denosumab therapy for osteoporosis during COVID-19 lockdown: an electronic medical record and pharmacy claims database study from Asia;Osteoporosis International;2021-08-21

4. High persistence over two years with denosumab among postmenopausal women with osteoporosis in France: A prospective cohort study;Bone;2021-05

5. Prior adherence to statins is a predictor of subsequent adherence and persistence to oral, but not parenteral, osteoporosis medications;Journal of Bone and Mineral Metabolism;2021-04-05